Merck & Co., Inc.
Merck & Co., Inc. reported 13 positions worth $526.4M as of June 30, 2026 (13F filed August 7, 2026). Largest holding: PSNL (35.8%).
| # | Symbol | Company | Type | Value ↓ | % Port. | Shares | 1Y | YTD |
|---|---|---|---|---|---|---|---|---|
| ▸ 1 | PSNL | SH | $188.2M | 35.75% | 14,044,943 | — | — | |
| ▸ 2 | MRNA | SH | $161.6M | 30.71% | 2,308,190 | — | — | |
| ▸ 3 | KYMR | SH | $88.5M | 16.82% | 772,165 | — | — | |
| ▸ 4 | AKTS | SH | $30.7M | 5.83% | 952,844 | — | — | |
| ▸ 5 | EIKN | SH | $21.7M | 4.13% | 1,666,666 | — | — | |
| ▸ 6 | TRDA | SH | $12.8M | 2.43% | 1,739,768 | — | — | |
| ▸ 7 | STRO | SH | $9.0M | 1.72% | 272,351 | — | — | |
| ▸ 8 | ALEC | SH | $7.1M | 1.35% | 3,545,719 | — | — | |
| ▸ 9 | EVAX | SH | $3.8M | 0.71% | 1,214,126 | — | — | |
| ▸ 10 | VRDN | SH | $1.7M | 0.33% | 93,414 | — | — |
The free plan shows the top 10 positions. The remaining 3 positions, the full portfolio and quarter changes unlock with Pro.
Pro Feature
This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.
Upgrade to ProRead the 2026-Q2 quarterly report · 13F Filing Calendar
Frequently Asked Questions
What stocks does Merck & Co., Inc. hold as of Q2 2026?
Merck & Co., Inc. reported 13 positions worth $526.4M in its Q2 2026 13F filing. Largest positions: PSNL (35.8%), MRNA (30.7%), KYMR (16.8%), AKTS (5.8%) and EIKN (4.1%).
What did Merck & Co., Inc. buy in Q2 2026?
No previous quarter is available yet; the comparison appears with the next filing.
What did Merck & Co., Inc. sell in Q2 2026?
No previous quarter is available yet.
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.